ICCC

$10.25-2.94%visit website

IMMUCELL CORP /DE/

Market Cap

$93M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.58

60mo monthly vs SPY

P/E (TTM)

146.4

TTM to Jun 2026 · diluted EPS

P/S (TTM)

3.0

TTM to Jun 2026 · revenue

P/B

3.0

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

14.7

TTM to Jun 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	5,506	7,626	10,357	7,186	30,676
Cost of revenue	3,143	4,716	5,700	4,749	18,308
Gross profit	2,363	2,910	4,657	2,437	12,368
Research & development	694	759	318	120	1,891
Total operating expenses	2,343	2,968	2,688	502	8,502
Operating income	20	(58)	1,969	1,935	3,866
Interest expense	135	106	100	96	436
Pretax income	(135)	(2,846)	1,954	1,881	854
Income tax	4.5	3.3	12.5	46.0	66.2
Net income	(140)	(2,849)	1,942	1,835	787
EPS (basic) ($)	(0.02)		0.21	0.20	0.08
EPS (diluted) ($)	(0.02)		0.21	0.20	0.07
Weighted avg. shares (basic)	9,046		9,046	9,065
Weighted avg. shares (diluted)	9,046		9,046	9,189

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

17 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Oct 13, 2026 accepted 10:01 AM ET	2.02Earnings release	Document SEC ↗
Aug 13, 2026 accepted 8:07 PM ET	2.02Earnings release	Document SEC ↗
Jul 9, 2026 accepted 8:08 PM ET	2.02Earnings release	Document SEC ↗
Jun 17, 2026 accepted 6:19 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 10, 2026 accepted 8:05 PM ET	7.01Reg FD disclosure	Document SEC ↗
May 14, 2026 accepted 8:09 PM ET	2.02Earnings release	Document SEC ↗
May 8, 2026 accepted 9:00 PM ET	1.01Material agreement	Document SEC ↗
Apr 14, 2026 accepted 11:18 PM ET	5.02Officer / director change8.01Other events	Document SEC ↗
Apr 8, 2026 accepted 8:05 PM ET	2.02Earnings release	Document SEC ↗
Mar 18, 2026 accepted 8:05 PM ET	5.02Officer / director change	Document SEC ↗